EVOFEM BIOSCIENCES, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Sep 2020 | -14.0% | -9,408.6% | -10,755.0% |
| Mar 2021 | 54.2% | -4,060.8% | -4,176.6% |
| Jun 2021 | 54.8% | -2,215.5% | -1,800.0% |
| Sep 2021 | 44.2% | -2,533.2% | -4,326.0% |
| Mar 2022 | 74.9% | -680.5% | -750.1% |
| Jun 2022 | 78.7% | -404.7% | -2,087.8% |
| Sep 2022 | 73.6% | -293.9% | 1,404.9% |
| Mar 2023 | 76.3% | -61.6% | -40.5% |
| Jun 2023 | 6.7% | -298.5% | -348.2% |
| Sep 2023 | 63.0% | -69.5% | 1,291.2% |
| Mar 2024 | 81.0% | -78.9% | -133.5% |
| Jun 2024 | 81.5% | -33.4% | 32.5% |
| Sep 2024 | 80.7% | -54.3% | -52.6% |
| Mar 2025 | 56.8% | 38.7% | 113.1% |
| Jun 2025 | 84.4% | -25.9% | -37.0% |
| Sep 2025 | 81.7% | 19.2% | -31.7% |
| Mar 2026 | 54.4% | -508.2% | -607.9% |
| Jun 2026 | 80.6% | -94.5% | -419.1% |